Atlas Trials

Study of the Effects of Mecamylamine and Varenicline in Schizophrenia

Clinical trial NCT00455650 · COMPLETED

Trial details

NCT number
NCT00455650
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cognition in Schizophrenia
Start date
2007-03-01
Primary completion
2013-01-01
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.